The nation of Zimbabwe has rejected a substantial US health deal valued at $367m (£272m) spanning five years over Washington's demand for sensitive biological samples.
This move was revealed after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "skewed".
A government spokesperson has since clarified that the US was demanding access to health data for research and commercial purposes while was unwilling to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued negotiations to find a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Broader Context
This rejection follows a comparable case in Kenya, where a high court suspended a related health funding agreement following legal challenges were raised about the security of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to boost transparency and responsibility.
According to statements, Sixteen nations in Africa have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research without any certainty that the final treatments would be accessible to our population if a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending frameworks already set up via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a manner that respects the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the nation's HIV programmes relied on international support.
"If specific concerns exist, including those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," it commented.
The situation underscores the complex challenges between receiving crucial foreign assistance and protecting local interests in an ever more data-driven world.